CHEO is a pediatric health-care and research centre located in Ottawa, Ontario, Canada. CHEO is also a tertiary trauma centre for children in Eastern Ontario, Nunavut, Northern Ontario and the Outaouais region of Quebec and one of only seven Level I trauma centres for children in Canada.

There are 167 beds in Children's Hospital of Eastern Ontario.

During the past decade, Children's Hospital of Eastern Ontario conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 81 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 40 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Hospital of Eastern Ontario" #1 sponsor was "Children's Oncology Group" with 109 trials, followed by "Children's Hospital of Eastern Ontario" with 57 trials sponsored, "The Hospital for Sick Children" with 30 trials sponsored, "National Cancer Institute (NCI)" with 21 trials sponsored and "Hoffmann-La Roche" with 21 trials sponsored. Other sponsors include 111 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Hospital of Eastern Ontario" #1 collaborator was "National Cancer Institute (NCI)" with 110 trials as a collaborator, "Children's Hospital of Eastern Ontario" with 31 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 23 trials as a collaborator, "The Hospital for Sick Children" with 13 trials as a collaborator and "St. Justine's Hospital" with 12 trials as a collaborator. Other collaborators include 347 different institutions and companies that were collaborators in the rest 200 trials.

According to Clinical.Site data, the most researched conditions in "Children's Hospital of Eastern Ontario" are "Leukemia" (19 trials), "Sarcoma" (13 trials), "Acute Lymphoblastic Leukemia" (12 trials), "Duchenne Muscular Dystrophy" (11 trials) and "Neuroblastoma" (11 trials). Many other conditions were trialed in "Children's Hospital of Eastern Ontario" in a lesser frequency.

Most popular intervention types in "Children's Hospital of Eastern Ontario" are "Drug" (191 trials), "Other" (108 trials), "Biological" (60 trials), "Procedure" (55 trials) and "Radiation" (50 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Cyclophosphamide" (32 trials), "Placebo" (31 trials), "Vincristine Sulfate" (29 trials) and "cyclophosphamide" (28 trials). Other intervention names were less common.

The vast majority of trials in "Children's Hospital of Eastern Ontario" are 321 trials for "All" genders, 17 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 118 active trials in "Children's Hospital of Eastern Ontario". 2 are not yet recruiting, 67 are recruiting, 46 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 192 completed trials in Children's Hospital of Eastern Ontario, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Hospital of Eastern Ontario, 20 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 67 trials that are defined as “Not Applicable".